Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3176944

NC(=O)C[C@H](N)C(N)=O.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRB2 P62993 1/20 0.36
ALOX15 P16050 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
KMT2A Q03164 1/20 0.35
DPP8 Q6V1X1 4/20 0.34
DPP7 Q9UHL4 3/20 0.34
PTPN1 P18031 2/20 0.33
DPP9 Q86TI2 1/20 0.32
NOS2 P35228 3/20 0.32
NOS3 P29474 2/20 0.32
NOS1 P29475 2/20 0.32
DPP4 P27487 1/20 0.31
S1PR1 P21453 4/20 0.31
S1PR3 Q99500 4/20 0.31
S1PR2 O95136 3/20 0.31
S1PR5 Q9H228 3/20 0.31
ODC1 P11926 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL28216351 1.00 GRB2 (0.36) GRB2ALOX15BLMPMP22KMT2A
Trifluoroacetic Acid SCHEMBL3176290 0.87 GRB2 (0.36) GRB2ALOX15BLMPMP22KMT2A
Trifluoroacetic Acid SCHEMBL29981273 0.87 GRB2 (0.36) GRB2ALOX15BLMPMP22KMT2A
Asparagine SCHEMBL30183111 0.87 ALOX15 (0.45) GRB2ALOX15BLMPMP22KMT2A
Asparagine SCHEMBL29663907 0.87 ALOX15 (0.45) GRB2ALOX15BLMPMP22KMT2A
SCHEMBL1263698 0.83
SCHEMBL195837 0.83
SCHEMBL195836 0.83
Trifluoroacetic Acid SCHEMBL20164118 0.82 ALOX15 (0.38) GRB2ALOX15BLMPMP22KMT2A
Ammonia Solution, Strong SCHEMBL25331273 0.81 ALOX15 (0.39) ALOX15BLMPMP22KMT2ADPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7645792-B2 Prodrugs of propofol, compositions and uses thereof XENOPORT, INC. (US) 2010-01-12 US disclosed
US-20090005352-A1 Prodrugs of Propofol, Compositions and Uses Thereof XENOPORT, INC. (US) 2009-01-01 US disclosed
US-7241807-B2 Prodrugs of propofol, compositions and uses thereof XENOPORT, INC. (US) 2007-07-10 US disclosed
US-20060041011-A1 Prodrugs of propofol, compositions and uses thereof XENOPORT, INC. 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060041011-A1 Prodrugs of propofol, compositions and uses thereof CYP2C19, CYP3A5, CYP3A4 GRB2 4848/4885ALOX15 638/4885BLM 3716/4885
US-20090005352-A1 Prodrugs of Propofol, Compositions and Uses Thereof CYP2C19, CYP3A5, CYP3A4 GRB2 4848/4885ALOX15 638/4885BLM 3716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.